RANDALL SCLAR: Open Payments
NPI 1255406468 · EVERGREEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 16 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $53 |
| Astellas Pharma US Inc | 2 | $53 |
| ABBVIE INC. | 2 | $39 |
| PFIZER INC. | 2 | $39 |
| Exact Sciences Corporation | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Corcept Therapeutics | 1 | $25 |
| Bausch Health US, LLC | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $20 |
Products named: REXULTI, GEMTESA, Veozah, PREVNAR 20, Cologuard Collection Kit, SHINGRIX, Korlym, QULIPTA.
Industry payments across CO — which companies pay providers there.
